Brief behavioral therapy for refractory insomnia in residual depression: An assessor-blind, randomized controlled trial

Journal of Clinical Psychiatry

Volumn 72, Issue 12, 2011, Pages 1651-1658

  Watanabe, Norio ^a   Furukawa, Toshi A ^a   Shimodera, Shinji ^c   Morokuma, Ippei ^c   Katsuki, Fujika ^b   Fujita, Hirokazu ^c   Sasaki, Megumi ^d   Kawamura, Chihiro ^c   Perlis, Michael L ^e  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

^d NARUTO UNIVERSITY OF EDUCATION   (Japan)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRID HAMILTON DEPRESSION RATING SCALE; HUMAN; INSOMNIA; INSOMNIA SEVERITY INDEX; MALE; NUMBERS NEEDED TO TREAT; OUTCOME ASSESSMENT; OUTPATIENT; PARALLEL DESIGN; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; REFRACTORY INSOMNIA; REMISSION; RESIDUAL DEPRESSION; SCORING SYSTEM; SLEEP PARAMETERS; TREATMENT DURATION;

EID: 84555194682     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06130gry     Document Type: Article

References (42)

1. Hamilton M. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry. 1989;154(2):201-206. doi:10.192/bjp.154.2.201 PubMed (Pubitemid 19050160)
2. Carney CE, Segal ZV, Edinger JD, et al. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. J Clin Psychiatry. 2007;68(2): 254-260. doi:10.408/JCP.v68n021 PubMed (Pubitemid 46362647)
3. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA. 1989;262(11): 1479-1484. doi:10.101/jama.262.1.1479 PubMed (Pubitemid 19220042)
4. McCall WV, Reboussin BA, Cohen W. Subjective measurement of insomnia and quality of life in depressed inpatients. J Sleep Res. 2000;9(1):43-48. doi:10.1046/j.1365-2869.20.0186.x PubMed (Pubitemid 30195292)
5. Turek FW. Insomnia and depression: if it looks and walks like a duck.... Sleep. 2005;28(11):1362-1363. PubMed (Pubitemid 41572786)
6. Perlis M, Smith M, Orff H. Major depressive disorder (MDD) is associated with a primary defect within the serotonergic system. Sleep Med Rev. 2002;6(5):353-357, discussion 359. PubMed doi:10.1016/S1087-0792(02)9024-3
7. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999;60(4):221-225. doi:10.408/JCP.v60n0403 PubMed (Pubitemid 29193918)
8. Dew MA, Reynolds CF 3rd, Houck PR, et al. Temporal profiles of the course of depression during treatment: predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry. 1997;54(11):1016-1024. PubMed (Pubitemid 27476097)
9. Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res. 2003;37(1):9-15. doi:10.1016/S02- 3956(02)052-3 PubMed (Pubitemid 35449766)
10. Pigeon WR, Hegel M, Unützer J, et al. Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort? Sleep. 2008;31(4):481-488. PubMed (Pubitemid 351694270)
11. Reynolds CF 3rd, Frank E, Houck PR, et al. Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication? Am J Psychiatry. 1997;154(7):958-962. PubMed (Pubitemid 27274538)
12. Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 2006;59(11):1052-1060. doi:10.1016/j.biopsych.206.01.016 PubMed (Pubitemid 43849658)
13. Manber R, Edinger JD, Gress JL, et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31(4):489-495. PubMed (Pubitemid 351694271)
14. Morin CM, Espie CA. Insomnia: A Clinical Guide to Assessment and Treatment. New York, NY: Guilford Press; 2004.
15. Perlis ML, Jungquist C, Smith MS, et al. Cognitive Behavioral Treatment of Insomnia: A Session-by-Session Guide. New York, NY: Springer Science; 2005.
16. Montgomery P, Dennis J. Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev. 2003; (1):CD003161. PubMed
17. Morin CM, Bootzin RR, Buysse DJ, et al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep. 2006;29(11):1398-1414. PubMed (Pubitemid 44764665)
18. Kitamura T, Tomita T, Okano S, et al. Structured Clinical Interview for DSM-IV Axis I Disorders. Tokyo, Japan: Nippon-Hyoron-sha Co, Ltd; 2003.
19. Berlim MT, Turecki G. Definition, assessment, and staging of treatmentresistant refractory major depression: a review of current concepts and methods. Can J Psychiatry. 2007;52(1):46-54. PubMed (Pubitemid 46743497)
20. Furukawa T, Akechi T, Ozaki N, et al. GRID-HDRS-17. Tokyo, Japan: The Japanese Society of Clinical Neuropsychopharmacology; 2003.
21. Tabuse H, Kalali A, Azuma H, et al. The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training. Psychiatry Res. 2007;153(1):61-67. doi:10.1016/j.psychres.206.07.04 PubMed (Pubitemid 47374824)
22. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001; 2(4):297-307. doi:10.1016/S1389-9457(0)065-4 PubMed (Pubitemid 32677404)
23. Munezawa T, Morin CM, Inoue Y, et al. Development of the Japanese version of the Insomnia Severity Index (ISI-J). Jap J Psychiatr Treat. 2009; 24(2):219-225.
24. Morin CM, Vallières A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005-2015. doi:10.101/jama.209. 682 PubMed
25. Furukawa TA, Akechi T, Azuma H, et al. Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression. J Clin Psychopharmacol. 2007;27(5):531-534. doi:10.1097/JCP.0b013e31814f30b1 PubMed (Pubitemid 47415066)
26. Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131(7):485-491. PubMed (Pubitemid 29482391)
27. Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213. doi:10.1016/0165-1781(89)9047-4 PubMed (Pubitemid 19144991)
28. Doi Y, Minowa M, Uchiyama M, et al. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res. 2000;97(2-3):165-172. doi:10.1016/S0165-1781(0)0232-8 PubMed (Pubitemid 32126555)
29. The WHO Collaborating Centre for Drug Statistics Methodology. ATC/ DDD (Defined Daily Dose) Index 2009. http://www.whocc.no/atcddd/. Accessed November 12, 2010.
30. Manber R, Edinger J, San Pedro M, et al. Combining escitalopram oxalate (EsCIT) and individual cognitive behavioral therapy for insomnia (CBTI) to improve depression outcome. Presented at the 21st Annual Meeting of the Associated Professional Sleep Societies;. June 9-14, 2007; Minneapolis, Minnesota.
31. Taylor DJ, Lichstein KL, Weinstock J, et al. A pilot study of cognitivebehavioral therapy of insomnia in people with mild depression. Behav Ther. 2007;38(1):49-57. doi:10.1016/j.beth.206.04.02 PubMed (Pubitemid 46209066)
32. Edinger JD, Wohlgemuth WK, Radtke RA, et al. Dose-response effects of cognitive-behavioral insomnia therapy: a randomized clinical trial. Sleep. 2007;30(2):203-212. PubMed
33. McCrae CS, McGovern R, Lukefahr R, et al. Research Evaluating Brief Behavioral Sleep Treatments for Rural Elderly (RESTORE): a preliminary examination of effectiveness. Am J Geriatr Psychiatry. 2007;15(11): 979-982. doi:10.1097/JGP.0b013e31813547e6 PubMed
34. Germain A, Moul DE, Franzen PL, et al. Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med. 2006;2(4):403-406. PubMed (Pubitemid 44763798)
35. SPSS Inc. SPSS for Windows. 16.0J ed. Tokyo, Japan: SPSS Japan Inc; 2007.
36. Brown H, Prescott R. Applied Mixed Models in Medicine. New York, NY: Wiley & Sons; 1999.
37. Altman DG, Schulz KF, Moher D, et al.; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663-694. PubMed (Pubitemid 32322245)
38. Edinger JD, Means MK. Cognitive-behavioral therapy for primary insomnia. Clin Psychol Rev. 2005;25(5):539-558. doi:10.1016/j.cpr.205.04.03 PubMed (Pubitemid 40943404)
39. Cuijpers P, Dekker J, Hollon SD, et al. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. J Clin Psychiatry. 2009;70(9):1219-1229. doi:10.408/JCP.09r05021 PubMed
40. Morin CM, Colecchi C, Stone J, et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999;281(11):991-999. doi:10.101/jama.281.1.91 PubMed (Pubitemid 29143890)
41. Naeem F, Gobbi M, Ayub M, et al. Psychologists experience of cognitive behaviour therapy in a developing country: a qualitative study from Pakistan. Int J Ment Health Syst. 2010;4(1):2. doi:10.186/1752-458-4-2 PubMed
42. Rathod S, Kingdon D, Smith P, et al. Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics-data on a previously published randomised controlled trial. Schizophr Res. 2005;74(2-3):211-219. (Pubitemid 40255079)